A federal judge in Manhattan has intervened to stop the Justice Department from obtaining medical records of transgender minors who received gender-affirming care, ordering a temporary restraining order against subpoenas issued to New York City health providers. This decision directly challenges the government’s attempt to access highly sensitive health information amid an ongoing political and legal battle over transgender healthcare.
The case emerged after the DOJ issued broad subpoenas demanding extensive medical data from institutions including NYU Langone Hospitals. These subpoenas targeted records for patients who received gender-affirming treatments as minors between 2020 and 2026. The court action arose from a class-action lawsuit filed by civil rights groups on behalf of transgender youth and young adults, who argue the subpoena demands violate patient confidentiality and privacy protections.
This legal conflict underscores a larger federal push to investigate and potentially restrict gender-affirming care for minors, provoking widespread concern among healthcare providers and civil advocacy organizations. According to plaintiff groups, similar subpoenas have been sent to over twenty healthcare institutions nationwide, prompting some hospitals to scale back or discontinue services for transgender youth amid fear of government scrutiny.
The preliminary ruling by Judge Katherine Polk Failla of the U.S. District Court for the Southern District of New York signals judicial recognition of the serious privacy interests at stake even before substantive legal arguments proceed. It presents a test case for federal authority limits in accessing private medical records during politically sensitive investigations, especially involving vulnerable populations such as transgender minors.
Beyond the immediate legal ramifications, the case has sparked unease among healthcare providers across the country, who watch closely to understand how courts will balance patient confidentiality against expansive government investigative powers. The outcome could influence the availability of gender-affirming care and the protection of medical privacy in future federal inquiries.